79 related articles for article (PubMed ID: 29145878)
1. Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial.
Lim WS; Meakin G; Brittain C; Bewick T; Duley L
Trials; 2017 Nov; 18(1):546. PubMed ID: 29145878
[TBL] [Abstract][Full Text] [Related]
2. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.
Lim WS; Brittain C; Duley L; Edwards S; Gordon S; Montgomery A; Nguyen-Van-Tam J; Read R; Whitham D; Whynes D; Woodhead M; Wootton D
Health Technol Assess; 2015 Feb; 19(16):1-78, vii-viii. PubMed ID: 25716702
[TBL] [Abstract][Full Text] [Related]
3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
4. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
Trials; 2018 May; 19(1):291. PubMed ID: 29793540
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
6. Strategies for successful rapid trials of influenza vaccine.
Scheifele DW; Marty K; LaJeunesse C; Fan SY; Bjornson G; Langley JM; Halperin SA
Clin Trials; 2011 Dec; 8(6):699-704. PubMed ID: 21900340
[TBL] [Abstract][Full Text] [Related]
7. Anticipation and response: pandemic influenza in Malawi, 2009.
Sambala EZ; Manderson L
Glob Health Action; 2017; 10(1):1341225. PubMed ID: 28753109
[TBL] [Abstract][Full Text] [Related]
8. Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study.
Venkatesan S; Myles PR; McCann G; Kousoulis AA; Hashmi M; Belatri R; Boyle E; Barcroft A; van Staa TP; Kirkham JJ; Nguyen Van Tam JS; Williams TJ; Semple MG
Health Technol Assess; 2015 Oct; 19(89):1-132. PubMed ID: 26514069
[TBL] [Abstract][Full Text] [Related]
9. Resource implications of preparing individual participant data from a clinical trial to share with external researchers.
Tudur Smith C; Nevitt S; Appelbe D; Appleton R; Dixon P; Harrison J; Marson A; Williamson P; Tremain E
Trials; 2017 Jul; 18(1):319. PubMed ID: 28712359
[TBL] [Abstract][Full Text] [Related]
10. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
11. Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza.
Bradbury N; Nguyen-Van-Tam J; Lim WS
BMC Health Serv Res; 2018 May; 18(1):311. PubMed ID: 29716584
[TBL] [Abstract][Full Text] [Related]
12. Hospital capacity and management preparedness for pandemic influenza in Victoria.
Dewar B; Barr I; Robinson P
Aust N Z J Public Health; 2014 Apr; 38(2):184-90. PubMed ID: 24690058
[TBL] [Abstract][Full Text] [Related]
13. Resilience training for hospital workers in anticipation of an influenza pandemic.
Aiello A; Khayeri MY; Raja S; Peladeau N; Romano D; Leszcz M; Maunder RG; Rose M; Adam MA; Pain C; Moore A; Savage D; Schulman RB
J Contin Educ Health Prof; 2011; 31(1):15-20. PubMed ID: 21425355
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
Oshansky CM; Zhou J; Gao Y; Schweinle JE; Biscardi K; DeBeauchamp J; Pavetto C; Wollish A; ; Webby RJ; Cioce V; Donis RO; Bright RA
Vaccine; 2019 Jan; 37(3):435-443. PubMed ID: 30553570
[TBL] [Abstract][Full Text] [Related]
15. Projection of participant recruitment to primary care research: a qualitative study.
White D; Hind D
Trials; 2015 Oct; 16():473. PubMed ID: 26482231
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.
Fukase H; Furuie H; Yasuda Y; Komatsu R; Matsushita K; Minami T; Suehiro Y; Yotsuyanagi H; Kusadokoro H; Sawata H; Nakura N; Lattanzi M
Vaccine; 2012 Jul; 30(33):5030-7. PubMed ID: 22472791
[TBL] [Abstract][Full Text] [Related]
17. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
[TBL] [Abstract][Full Text] [Related]
18. The PAndemic INfluenza Triage in the Emergency Department (PAINTED) pilot cohort study.
Goodacre S; Irving A; Wilson R; Beever D; Challen K
Health Technol Assess; 2015 Jan; 19(3):v-xxi, 1-69. PubMed ID: 25587699
[TBL] [Abstract][Full Text] [Related]
19. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.
Gobat NH; Gal M; Francis NA; Hood K; Watkins A; Turner J; Moore R; Webb SA; Butler CC; Nichol A
Trials; 2015 Dec; 16():591. PubMed ID: 26715077
[TBL] [Abstract][Full Text] [Related]
20. Recruitment effort and costs from a multi-center randomized controlled trial for treating depression in type 2 diabetes.
Myers BA; Pillay Y; Guyton Hornsby W; Shubrook J; Saha C; Mather KJ; Fitzpatrick K; de Groot M
Trials; 2019 Nov; 20(1):621. PubMed ID: 31694682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
